Showing results (21-30 of 23) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical Drug Investigation|July 12, 2025
Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid ArthritisGerd Burmester, Jakub Trefler, Artur Racewicz, et al.Expert Opinion on Investigational Drugs|May 26, 2023
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I studyKyung-Sang Yu, Byungwook Kim, Dongseong Shin, et al.RMD Open|October 18, 2024
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47Josef S Smolen, Jakub Trefler, Artur Racewicz, et al.Pageof 3